Haloperidol-desipramine interaction in mice, rats and man.
D000818:Animals; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D001544:Benperidol / Q000009:adverse effects; D002090:Butyrophenones / Q000009:adverse effects; D002908:Chronic Disease; D003891:Desipramine / Q000494:pharmacology* / Q000627:therapeutic use; D004336:Drug Antagonism; D005260:Female; D006220:Haloperidol / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008297:Male; D051379:Mice; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D009966:Orphenadrine / Q000009:adverse effects; D011618:Psychotic Disorders / Q000188:drug therapy; D051381:Rats; D014202:Tremor / Q000139:chemically induced
D002090:Butyrophenones; D001544:Benperidol; D009966:Orphenadrine; D006220:Haloperidol; D003891:Desipramine